C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
MJJ Equity

MJJ

OTCMKTS · MJJ

$73.21
—
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
42/100 composite
Fundamentals40
Regulatory55
Market40
Editorial30
Composite · trailing 12 months

CIN assigns Microsectors Cannabis 3x ETN a Neutral rating with low conviction, reflecting a composite score in the low forties. Regulatory is the strongest pillar, reaching the mid-fifties on a favorable global jurisdiction posture and a clean enforcement profile. Fundamentals and market support each sit near forty, leaving neither pillar strong enough to broaden the case. Editorial support ranks lowest at roughly thirty because CIN newsroom coverage contains no recent newsroom or brief activity. The resulting profile supports the Neutral band: regulatory structure provides relative stability, while absent operating, pricing, and editorial confirmation caps conviction.

Underlying data remain sparse. Licensed fundamentals data provide no revenue growth, margin, or financial-condition evidence for the instrument, preventing the fundamentals pillar from establishing an operating trend. Institutional pricing feeds provide no current quote, so the market pillar cannot assess momentum, volatility, or price confirmation. Filing cadence is the principal regulatory weakness. Primary regulatory filings show no latest filing date, while the trailing ninety-day and 180-day windows contain no recorded events. That inactivity drives the cadence subscore into the mid-twenties despite a jurisdiction score near seventy and an enforcement subscore near eighty. The absence of enforcement hits supports the regulatory pillar, but it does not substitute for current filing activity. CIN newsroom coverage also records no newsroom hits or briefs, reinforcing the limited information flow reflected in the editorial score.

The forward catalyst rests squarely on regulatory disclosure, the highest-rated pillar. A newly dated primary regulatory filing would lift cadence from its depressed level, refresh the instrument’s disclosure record, and validate the stronger jurisdiction and enforcement components already carrying the rating. That improvement could raise conviction without relying on unavailable revenue, margin, or quote data. Conversely, continued filing inactivity would preserve the current imbalance between favorable regulatory posture and weak disclosure frequency, keeping the composite anchored in Neutral territory. The single most important signal to watch is the appearance of a newly dated primary regulatory filing.

Scored: 2026-10-16Valid through: 2026-11-30Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
777 Brickell Ave Miami, FL 33131
Phone
1-877-369-5412
CEO
Greg King Founder
CFO
Robert Rokose
Website
Company website
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for MJJ (MJJ)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for MJJ (MJJ), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Neutral / Wait. Mixed data profile. Await clearer directional signal. (0 bullish signals, 0 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for MJJ are maintained by Cannabis Investor News and refreshed throughout the trading day.